Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Building an MBMA Framework to Support Developing New Neuropathic Pain Drugs

April 24, 2019 – Model-Based Meta-Analysis (MBMA) is a growing methodology that leverages literature based and often external data to provide a quantitative framework to enable strategic drug development decisions. MBMA comparator models often include valuable pieces of information such as time, covariates, clinical trial efficacy and safety information.

Speaker(s): Leticia Arrington, Richard C. Franzese
Solution: Model-based Meta-analysis, PK/PD Modeling & Simulation
Therapeutic Area: Central Nervous System
More Info

Found in Translation: Building an Early Development Strategy for Complex Biologics

April 30, 2019 This webinar will describe some important strategic considerations for successful development of complex biologics including appropriate data collection and timings, analyses requiring cross-functional data integration, and key pharmacology-related critical questions.

Speaker(s): Aaron Moss, Christina Mayer
Solution: Clinical Pharmacology Strategy, PK/PD Modeling & Simulation
Therapeutic Area: Oncology/Hematology, Rare/Orphan Disease
More Info
Learn More LinkedIn Twitter Facebook Email